Delivery Order SPE2DB22D2211-SPE2DB25FRYEC
Award Date 5/30/25
Potential Completion Date 6/2/25
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,175.33 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50s, a critical antibiotic medication. This firm fixed-price, competitively awarded delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The pharmaceuticals will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations....
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,464.38, is for the delivery of Meropenem-0.9% Sodium Chloride 1 Gram/50s, a pharmaceutical product. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,625.71, is for the supply of MEROPENEM-0.9% NACL 1 GRAM/50S, a pharmaceutical product. The contract has an ultimate completion date of January 3, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,940.78 firm fixed-price delivery order is for the supply of Meropenem 2 gram vials, a critical antibiotic medication. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,991.42, is to provide MEROPENEM-0.9% NACL 1 GRAM/50S, a medical product used in healthcare settings. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 4, 2025, by the Defense Logistics Agency (DLA) for the supply of Cefepime-Dextrose 2 GM/50 MLS. This competitively awarded, firm fixed-price delivery order is valued at $12,695.91 and carries an ultimate completion date of September 5, 2025. The product will be delivered to the Conshohocken, PA location. As a child contract under a larger vehicle,...
- The Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of ertapenem 1 gram vials, a broad-spectrum antibiotic used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $1,457.56, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999.999 billion and...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,269.70 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, for the supply of Ertapenem 1 gram vials. This competitively awarded, firm fixed-price contract has an ultimate completion date of July 22, 2025, and represents a small-value pharmaceutical procurement with no set-aside designation. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,791.64 to AmerisourceBergen Drug Corp for the supply of Imipenem-Cilastatin 500 mg vials. This firm fixed-price delivery order was awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, and represents a non-competitive delivery against AmerisourceBergen's existing indefinite delivery contract. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency's Medical Supply Chain awarded a $33,874.61 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for pharmaceutical products and medical supplies. The contract, which is non-set-aside and competitively awarded, is a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. AmerisourceBergen, headquartered in Conshohocken,...